Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Şahİn, SERDAR; HalİloĞlu, Özlem; Polat Korkmaz, Özge; Durcan, EMRE; Rekali Şahİn, HÜmeyra; Yumuk, VOLKAN; Damci, Taner; İlkova, Hasan; OŞar Sİva, Zeynep

doi:10.3906/sag-2008-37

Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Şahİn S., HalİloĞlu Ö., Polat Korkmaz Ö., Durcan E., Rekali Şahİn H., Yumuk V. D., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.2, ss.735-742, 2021 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.3906/sag-2008-37
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.735-742
Anahtar Kelimeler: Anxiety, sleep quality, quality of life, sodium-glucose co-transporter 2 inhibitor, INADEQUATE GLYCEMIC CONTROL, SGLT2 INHIBITORS, DOUBLE-BLIND, DAPAGLIFLOZIN, PREVALENCE, HEALTH, ADULTS, HYPOGLYCEMIA, ASSOCIATION, INFECTIONS
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).